Select Publications
Journal articles
2017, 'Chromosome preference of disease genes and vectorization for the prediction of non-coding disease genes', Oncotarget, 8, pp. 78901 - 78916, http://dx.doi.org/10.18632/oncotarget.20481
,2017, 'Upregulation of LYAR induces neuroblastoma cell proliferation and survival', Cell Death and Differentiation, 24, pp. 1645 - 1654, http://dx.doi.org/10.1038/cdd.2017.98
,2016, 'NCYM is upregulated by lncUSMycN and modulates N-Myc expression', International Journal of Oncology, 49, pp. 2464 - 2470, http://dx.doi.org/10.3892/ijo.2016.3730
,2016, 'Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia', Leukemia, 30, pp. 1745 - 1748, http://dx.doi.org/10.1038/leu.2016.24
,2016, 'INPP4B is an oncogenic regulator in human colon cancer', Oncogene, 35, pp. 3049 - 3061, http://dx.doi.org/10.1038/onc.2015.361
,2016, 'Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation', Cell Death and Disease, 7, pp. e2252 - e2252, http://dx.doi.org/10.1038/cddis.2016.123
,2016, 'The bromodomain inhibitor jq1 and the histone deacetylase inhibitor panobinostat synergistically reduce n-myc expression and induce anticancer effects', Clinical Cancer Research, 22, pp. 2534 - 2544, http://dx.doi.org/10.1158/1078-0432.CCR-15-1666
,2016, 'High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients', Cancer Letters, 374, pp. 315 - 323, http://dx.doi.org/10.1016/j.canlet.2016.02.021
,2016, 'MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4', Oncotarget, 7, pp. 54937 - 54951, http://dx.doi.org/10.18632/oncotarget.10709
,2016, 'The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs', Oncotarget, 7, pp. 79217 - 79232, http://dx.doi.org/10.18632/oncotarget.12640
,2016, 'The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression', Oncotarget, 7, pp. 8663 - 8675, http://dx.doi.org/10.18632/oncotarget.6675
,2015, 'WDR5 supports an N-myc transcriptional complex that drives a protumorigenic gene expression signature in neuroblastoma', Cancer Research, 75, pp. 5143 - 5154, http://dx.doi.org/10.1158/0008-5472.CAN-15-0423
,2015, 'Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma', Science Translational Medicine, 7, pp. 312ra176, http://dx.doi.org/10.1126/scitranslmed.aab1803
,2015, 'Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma', Molecular Oncology, 9, pp. 1484 - 1500, http://dx.doi.org/10.1016/j.molonc.2015.04.005
,2015, 'IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma', Journal of Clinical Oncology, 33, pp. 1285 - 1293, http://dx.doi.org/10.1200/JCO.2014.55.9880
,2015, 'Connecting rules from paired miRNA and mRNA expression data sets of HCV patients to detect both inverse and positive regulatory relationships', BMC Genomics, 16, pp. s11, http://dx.doi.org/10.1186/1471-2164-16-S2-S11
,2015, 'Erratum: Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression (Journal of the National Cancer Institute (2014) 106:7 (dju113) DOI: 10.1093/jnci/dju113)', Journal of the National Cancer Institute, 107, http://dx.doi.org/10.1093/jnci/dju359
,2015, 'INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas', Oncotarget, 6, pp. 39891 - 39907, http://dx.doi.org/10.18632/oncotarget.5359
,2015, 'Population testing for cancer predisposing BRCA1/BRCA2 mutations in the ashkenazi-jewish community: A randomized controlled trial', Journal of the National Cancer Institute, 107, http://dx.doi.org/10.1093/jnci/dju379
,2015, 'The histone methyltransferase DOT1L: Regulatory functions and a cancer therapy target', American Journal of Cancer Research, 5, pp. 2823 - 2837
,2014, 'Effects of a Novel Long Noncoding RNA, lncUSMycN, on N-Myc Expression and Neuroblastoma Progression', Journal of the National Cancer Institute, 106, pp. dju113, http://dx.doi.org/10.1093/jnci/dju113
,2014, 'The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc', PLoS ONE, 9, pp. e88112, http://dx.doi.org/10.1371/journal.pone.0088112
,2014, 'The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1', Oncotarget, 5, pp. 1793 - 1804, http://dx.doi.org/10.18632/oncotarget.1785
,2014, 'Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach', Journal of Proteomics, 96, pp. 1 - 12, http://dx.doi.org/10.1016/j.jprot.2013.10.032
,2014, 'Histone Deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1', Oncotarget, 5, pp. 4257 - 4268, http://dx.doi.org/10.18632/oncotarget.1991
,2014, 'Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein', Oncology Reports, 31, pp. 1935 - 1939, http://dx.doi.org/10.3892/or.2014.3006
,2014, 'Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A
2014, 'The prenatal origins of cancer', Nature Reviews Cancer, 14, pp. 277 - 289, http://dx.doi.org/10.1038/nrc3679
,2014, 'TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells', Oncotarget, 5, pp. 10127 - 10139, http://dx.doi.org/10.18632/oncotarget.2466
,2013, 'Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3', Cell Death and Disease, 4, pp. e655 - e655, http://dx.doi.org/10.1038/cddis.2013.192
,2013, 'Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation', Oncogene, 32, pp. 3616 - 3626, http://dx.doi.org/10.1038/onc.2012.368
,2013, 'FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation', Leukemia, 27, pp. 1053 - 1062, http://dx.doi.org/10.1038/leu.2012.361
,2013, 'Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc', Oncogene, 33, pp. 2987 - 2994, http://dx.doi.org/10.1038/onc.2013.253
,2013, 'PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma', Nature communications, 4, pp. Article number 1508, http://dx.doi.org/10.1038/ncomms2489
,2013, 'Sirtuin-1 regulates acinar to ductal metaplasia and supports cancer cell viability in pancreatic cancer', Cancer research, 73, pp. 2357 - 2367, http://dx.doi.org/10.1158/0008-5472.CAN-12-3359
,2013, 'The histone deacetylase SIRT2 stabilizes Myc oncoproteins', Cell Death and Differentiation, 20, pp. 503 - 514, http://dx.doi.org/10.1038/cdd.2012.147
,2013, 'Tumor protein 53-induced nuclear protein 1 enhances p53 function and represses tumorigenesis', Frontiers in Genetics, 13, pp. Art. No. 80, http://dx.doi.org/10.3389/fgene.2013.00080
,2013, 'Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stress', The Journal of Biological Chemistry, 288, pp. 12032 - 12041, http://dx.doi.org/10.1074/jbc.M112.447821
,2012, 'Upregulation of survivin during immortalization is linked to repression of p16INK4a and confers resistance to oxidative stress', CANCER RESEARCH, 72, http://dx.doi.org/10.1158/1538-7445.AM2012-2196
,2012, 'Amide-based derivatives of â-alanine hydroxamic acid as histone deacetylase inhibitors: Attenuation of potency through resonance effects', Bioorganic and Medicinal Chemistry Letters, 22, pp. 6200 - 6204, http://dx.doi.org/10.1016/j.bmcl.2012.08.006
,2012, 'Enhancing the anticancer effect of the histone deacetylase inhibitor by activating transglutaminase', European Journal of Cancer, 48, pp. 3278 - 3287, http://dx.doi.org/10.1016/j.ejca.2012.02.067
,2012, 'Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress', Cell Death & Disease, 3, pp. e337, http://dx.doi.org/10.1038/cddis.2012.79
,2011, 'SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability', PLOS Genetics, 7, pp. e1 - e14, http://dx.doi.org/10.1371/journal.pgen.1002135
,2011, 'The histone deacetylase SIRT1 promotes N-Myc-induced neuroblastoma by stabilizing N-Myc protein', PLoS Genetics, 7, pp. e1002135
,2010, 'MYCN oncoprotein targets and their therapeutic potential', Cancer Letters, 293, pp. 144 - 157, http://dx.doi.org/10.1016/j.canlet.2010.01.015
,2010, 'Opposing Effects of Two Tissue Transglutaminase Protein Isoforms in Neuroblastoma Cell Differentiation', The Journal of Biological Chemistry, 285, pp. 3561 - 3567, http://dx.doi.org/10.1074/jbc.M109.053041
,2010, 'Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects', Oncogene, 29, pp. 5957 - 5968, http://dx.doi.org/10.1038/onc.2010.332
,2010, 'TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells', Oncogene, 29, pp. 6172 - 6183, http://dx.doi.org/10.1038/onc.2010.340
,2009, 'Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors', European Journal of Cancer, 45, pp. 1846 - 1854, http://dx.doi.org/10.1016/j.ejca.2009.03.002
,2009, 'The critical role of the class III histone deacetylase SIRT1 in cancer', Cancer Research, 69, pp. 1702 - 1705, http://dx.doi.org/10.1158/0008-5472.CAN-08-3365
,